½ÃÀ庸°í¼­
»óǰÄÚµå
1618602

¼¼°èÀÇ ÀÇ·á±â±â Àçó¸® ½ÃÀå : ÇÁ·Î¼¼½º, µµÀÔ ¹æ¹ý, À¯Çü, Àçó¸® ÀÇ·á±â±â, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)

Medical Device Reprocessing Market by Process (Disinfection, Initial Cleaning, Sterilization), Method of Deployment (Off-Site Reprocessing, On-Site Reprocessing), Type, Reprocessing Medical Devices, End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 187 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ÀÇ·á±â±â Àçó¸® ½ÃÀåÀº 2023³â¿¡ 26¾ï ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 29¾ï 5,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 13.39%·Î ¼ºÀåÇϰí, 2030³â¿¡´Â 62¾ï 9,000¸¸ ´Þ·¯°¡ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÇ·á±â±â Àç󸮶õ »ç¿ëÇÑ ÀÇ·á±â±â¸¦ ¼¼Ã´, ¸ê±Õ, Àç»ç¿ëÇÏ´Â È¿°úÀûÀÎ ÇÁ·Î¼¼½º¸¦ ¸»ÇÕ´Ï´Ù. ÀÇ·á±â±â Àçó¸®ÀÇ Çʿ伺Àº ºñ¿ë´ëºñ È¿°ú°¡ ÀÖ´Â ÀÇ·á ¿ëǰ¿¡ ´ëÇÑ ¼ö¿äÀÇ ³ô¾Æ, ȯ°æ¿¡ ´ëÇÑ ¿ì·Á, ÀÇ·á ½Ã¼³¿¡ ¾ÈÀüÇÑ Àçó¸® ¹æ¹ýÀ» ä¿ëÇÒ °ÍÀ» Àǹ«È­ÇÏ´Â ¾ö°ÝÇÑ ±ÔÁ¦ °¡À̵å¶óÀÎÀ¸·ÎºÎÅÍ ¹ß»ýÇÕ´Ï´Ù. ÀÌ ¿ëµµ´Â ¼ö¼ú±â±¸, Ä«Å×ÅÍ, ³»½Ã°æ°ú °°Àº ´ÜÀÏ »ç¿ë ¹× ´Ùȸ »ç¿ëÀÇ ±¤¹üÀ§ÇÑ Àåºñ ¹× ÃÖÁ¾ »ç¿ëÀÚ´Â º´¿ø, Ŭ¸®´Ð, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)¸¦ Æ÷ÇÔÇÕ´Ï´Ù. ÀÇ·áºñ Áõ°¡, ȯ°æ Áö¼Ó°¡´É¼º ¸ñÇ¥ ´Þ¼º¿¡ ¾Ð·Â µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ Á¤ºÎÀÇ ¾ö°ÝÇÑ ±ÔÁ¦´Â ¾ÈÀüÇÑ Àç󸮸¦ Áß½ÃÇÏ°í ¼­ºñ½º Á¦°ø¾÷ü¿¡°Ô ¼ºÀå ±âȸ¸¦ °¡Á®¿À°í ÀÖ½À´Ï´Ù. ±×·¯³ª °úÁ¦´Â Áö¿ª °£ÀÇ ´Ù¾çÇÑ ±ÔÁ¦ ±âÁØ¿¡ ´ëÇÑ ÀϰüµÈ ÄÄÇöóÀ̾𽺠Ȯº¸, ÀåÄ¡ ¹«°á¼º¿¡ ´ëÇÑ ÀáÀçÀûÀΠȯÀÚ ¾ÈÀü ¿ì·Á, Àçó¸® ½Ã¼³ ¼³¸³ÀÇ Ãʱ⠺ñ¿ë »ó½Â µîÀÔ´Ï´Ù. ȯ°æ ģȭÀûÀÎ Àçó¸®Á¦ÀÇ °³¹ß°ú ¿­¿¡ ¹Î°¨ÇÑ ÀåÄ¡¿¡ ´ëÇÑ Àú¿Â ¸ê±Õ°ú °°Àº ¸ê±Õ ±â¼úÀÇ °­È­¸¦ ¸ñÇ¥·Î ÇÒ ¼ö ÀÖ½À´Ï´Ù. ǰÁú º¸Áõ ÇÁ·ÎÅäÄÝÀÇ °³¹ß¿¡ ÃÊÁ¡À» ¸ÂÃâ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀåÀº º»ÁúÀûÀ¸·Î ¿ªµ¿ÀûÀÌ¸ç ±ÔÁ¦ ÁÖµµÇüÀ̱⠶§¹®¿¡ ²÷ÀÓ¾ø´Â ÀûÀÀÀÌ ¿ä±¸µË´Ï´Ù. °Ç°­ °ü¸® ±â°ü°úÀÇ Çù·Â¿¡ ÅõÀÚÇØ¾ßÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 26¾ï ´Þ·¯
ÃßÁ¤³â(2024) 29¾ï 5,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 62¾ï 9,000¸¸ ´Þ·¯
CAGR(%) 13.39%

½ÃÀå ¿ªÇÐ: ±Þ¼ÓÈ÷ ÁøÈ­ÇÏ´Â ÀÇ·á±â±â Àçó¸® ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

ÀÇ·á±â±â Àçó¸® ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. Á¤¹ÐÈ­ ¹× »õ·Î¿î ºñÁî´Ï½º ±âȸ ȹµæ¿¡ ´ëºñÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦ÀûÀÎ ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ½°ú µ¿½Ã¿¡ ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¼¼°èÀÇ ¿Ü°ú ¼ö¼ú °Ç¼ö Áõ°¡
    • ¼¼°èÀÇ ÇコÄɾÀÎÇÁ¶ó¿¡ÀÇ ÁöÃâ Áõ°¡
    • ÇコÄɾ À־ÀÇ Áö¼Ó°¡´É¼ºÀ» Á¦Ã¢ÇÏ´Â Á¤ºÎÀÇ µÞ¹Þħ Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • Àç°¡°ø ÀÇ·á±â±â ¾ÈÀü¼º°ú À¯È¿¼º¿¡ ´ëÇÑ ¿ì·Á
  • ½ÃÀå ±âȸ
    • ¾Æ¿ô¼Ò½Ì¿¡ Å« ÁÖ¸ñ ÀÇ·á±â±â Àçó¸®
    • ¶Ù¾î³­ »ì±Õ¹ý °³¹ßÀ» À§ÇÑ R&D ÅõÀÚ
  • ½ÃÀåÀÇ °úÁ¦
    • Ç¥ÁØÈ­µÈ Àçó¸® ÇÁ·ÎÅäÄÝÀÇ ºÎÁ·°ú ÇÔ²², Àçó¸® °¡´ÉÇÑ ±â±âÀÇ ÇѰè

Porter's Five Force : ÀÇ·á±â±â Àçó¸® ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Force Framework´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù. ´ç½ÅÀº ´õ °­ÀÎÇÑ ½ÃÀå¿¡¼­ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ÀÇ·á±â±â Àçó¸® ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍÀÇ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ÀÇ·á±â±â Àçó¸® ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇϴµ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÏ¸é ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ°¡µÇ¾î ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ÀÇ·á±â±â Àçó¸® ½ÃÀå¿¡¼­°æÀï ±¸µµ ÆÄ¾Ç

ÀÇ·á±â±â Àçó¸® ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. À̸¦ ÅëÇØ ½ÃÀåÀÇ ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í, º¥´õ´Â °æÀïÀÌ °ÝÈ­ÇÏ´Â °¡¿îµ¥ ÀÚ½ÅÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» Çϱâ À§ÇØ ÇÊ¿äÇÕ´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ÀÇ·á±â±â Àç ó¸® ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ÀÇ·á±â±â Àçó¸® ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Á¤º¸¸¦ ±â¹ÝÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ºÎ¹®È­Çϰí Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·«ºÐ¼® ¹× Ãßõ : ÀÇ·á±â±â Àçó¸® ½ÃÀå¿¡¼­ ¼º°øÀ» À§ÇÑ ±æÀ» ±×¸®±â

ÀÇ·á±â±â Àçó¸® ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ ¹æ¹ýÀ» »ç¿ëÇÏ¸é °æÀï ±¸µµ¿¡¼­ ¾î·Á¿òÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ: ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­: ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¼¼°è¿¡¼­ ¿Ü°ú ¼ö¼ú °Ç¼ö°¡ Áõ°¡
      • ¼¼°è ÇコÄɾî ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÁöÃâÀÌ Áõ°¡
      • ÇコÄɾ À־ÀÇ Áö¼Ó°¡´É¼ºÀ» ÃßÁøÇϱâ À§ÇÑ Á¤ºÎÀÇ ´ëó°¡ Áõ°¡
    • ¾ïÁ¦¿äÀÎ
      • Àç°¡°øµÈ ÀÇ·á±â±â ¾ÈÀü¼º°ú À¯È¿¼º¿¡ ´ëÇÑ ¿ì·Á
    • ±âȸ
      • ¾Æ¿ô¼Ò½Ì¿¡ ÁßÁ¡À» µÐ ÀÇ·á±â±â Àçó¸®
      • ¶Ù¾î³­ ¸ê±Õ ¹æ¹ý °³¹ßÀ» À§ÇÑ ¿¬±¸ °³¹ß ÅõÀÚ
    • °úÁ¦
      • Àçó¸® °¡´ÉÇÑ µð¹ÙÀ̽ºÀÇ Á¦ÇѰú Ç¥ÁØÈ­µÈ Àçó¸® ÇÁ·ÎÅäÄÝÀÇ ºÎÁ·
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
    • ÇÁ·Î¼¼½º: ¾ÈÀü¼º°ú À¯È¿¼ºÀ» È®º¸ÇÏ´Â Áõ±â ¸ê±Õ ¼ö¿ä Áõ°¡
    • Àçó¸® ÀÇ·á±â±â: ½ÉÇ÷°ü ¼ö¼ú¿¡¼­ ÀÇ·á±â±â Àç󸮿¡ ÀÇÇÑ °æÁ¦Àû ¹× Áö¼Ó°¡´É¼ºÀÇ ÀåÁ¡ ±Ø´ëÈ­
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå ÀÇ·á±â±â Àçó¸® ½ÃÀå : ÇÁ·Î¼¼½ºº°

  • ¼Òµ¶
    • °íµµ ¼Òµ¶
    • Áßµµ ¼Òµ¶
  • Ãʱâ û¼Ò
    • ÀÚµ¿ û¼Ò
    • ¼öµ¿ û¼Ò
  • »ì±Õ
    • ¿¡Æ¿·»¿Á»çÀ̵å
    • ½ºÆÀ

Á¦7Àå ÀÇ·á±â±â Àçó¸® ½ÃÀå : Àü°³ ¹æ¹ýº°

  • ¿ÀÇÁ»çÀÌÆ® Àçó¸®
  • ÇöÀå Àçó¸®

Á¦8Àå ÀÇ·á±â±â Àçó¸® ½ÃÀå : À¯Çüº°

  • È¿¼Ò
  • ºñÈ¿¼Ò ¼¼Á¦

Á¦9Àå ÀÇ·á±â±â Àçó¸® ½ÃÀå : Àçó¸® ÀÇ·á±â±â

  • ½ÉÀåÇ÷°ü
  • ¼ÒÈ­±â ³»°ú
  • ÀÏ¹Ý ¼ö¼ú
  • º¹°­°æ
  • Á¤Çü¿Ü°ú/°üÀý°æ

Á¦10Àå ÀÇ·á±â±â Àçó¸® ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • Áø´Ü¼¾ÅÍ
  • º´¿ø ¹× Ŭ¸®´Ð

Á¦11Àå ¾Æ¸Þ¸®Ä«ÀÇ ÀÇ·á±â±â Àçó¸® ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦12Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÇ·á±â±â Àçó¸® ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦13Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÀÇ·á±â±â Àçó¸® ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦14Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
    • AA MedicalÀº ÇコÄɾî ÀÚ»ê °ü¸® ¹× Àçó¸® ±â´ÉÀ» °­È­Çϱâ À§ÇØ Tekyard, Zantek Medical, MED-SELLCOM°úÀÇ Àü·«Àû Á¦ÈÞ¸¦ ¹ßÇ¥
    • Getinge°¡ Healthmark Industries¸¦ Àμö, ½ÃÀå ¹üÀ§¸¦ È®´ëÇØ ÀÇ·á½Ã¼³¿ëÀÇ Àçó¸® ¼Ö·ç¼ÇÀ» °­È­
    • Olympus´Â Çõ½ÅÀûÀÎ ETD ³»½Ã°æ ¼¼Ã´ ¼Òµ¶ ÀåÄ¡¸¦ µµÀÔÇÏ¿© EMEA Áö¿ª Àüü¿¡¼­ ÀÇ·á±â±â Àçó¸®ÀÇ ¾ÈÀü¼º, È¿À²¼º, ȯ°æ¿¡ ´ëÇÑ ¹è·Á¸¦ °­È­Çß½À´Ï´Ù.
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • 3M Company
  • Advanced Sterilization Products
  • Avante Health Solutions
  • Belimed AG
  • Cardinal Health, Inc.
  • Ecolab USA Inc.
  • Fujifilm Holdings Corporation
  • GE Healthcare Technologies Inc.
  • Getinge AB
  • Innovative Health LLC
  • Johnson & Johnson Services, Inc.
  • Karl Storz SE & Co. KG
  • Medifix Solutions Pty Ltd.
  • Medline Industries, Inc.
  • NEScientific, Inc.
  • Olympus Corporation
  • Pioneer Medical Devices AG
  • ReNu Medical, Inc.
  • Richard Wolf GmbH
  • Ruhof Corporation
  • Smith & Nephew PLC
  • Sotera Health Company
  • SteriPro Canada, Inc.
  • Steris PLC
  • Stryker Corporation
  • SureTek Medical Inc.
  • Teleflex Incorporated
  • UVC Solutions doo
  • Vanguard AG
  • Zimmer Biomet Holdings, Inc.
JHS 24.12.30

The Medical Device Reprocessing Market was valued at USD 2.60 billion in 2023, expected to reach USD 2.95 billion in 2024, and is projected to grow at a CAGR of 13.39%, to USD 6.29 billion by 2030.

Medical device reprocessing refers to the validated process of cleaning, sterilizing, and re-purposing used medical devices to ensure they are safe for reuse. It's a vital facet of healthcare that aims to enhance sustainability, lower healthcare costs, and reduce medical waste in clinical settings. The necessity for medical device reprocessing arises from the growing demand for cost-effective medical supplies, environmental concerns, and stringent regulatory guidelines mandating healthcare facilities to adopt safe reprocessing practices. The application spans a wide array of single-use and multi-use devices like surgical instruments, catheters, and endoscopes, with end-users including hospitals, clinics, and ambulatory surgical centers. Key growth influencers include advancements in sterilization technologies, increasing healthcare expenditure, and the pressure to meet environmental sustainability goals. Moreover, stringent government regulations emphasize safe reprocessing practices, thereby creating growth opportunities for service providers. The latest opportunities lie in the integration of AI and IoT technologies to automate processes and improve traceability and compliance. Companies should also explore partnerships with hospitals to provide customized reprocessing services, leveraging big data analytics for optimization and insight. However, challenges include ensuring consistent compliance with diverse regulatory standards across regions, potential patient safety concerns regarding device integrity, and the high initial cost of establishing reprocessing facilities. Innovation can target the development of eco-friendly reprocessing agents and enhanced sterilization technologies, like low-temperature sterilization for heat-sensitive devices. Research could focus on improving material durability for better reusability and developing advanced quality assurance protocols. The market is inherently dynamic and regulatory-driven, demanding constant adaptation. Businesses should invest in robust R&D, regulatory compliance strategies, and collaborations with healthcare institutions to remain competitive and meet evolving safety standards.

KEY MARKET STATISTICS
Base Year [2023] USD 2.60 billion
Estimated Year [2024] USD 2.95 billion
Forecast Year [2030] USD 6.29 billion
CAGR (%) 13.39%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Medical Device Reprocessing Market

The Medical Device Reprocessing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing number of surgical procedures worldwide
    • Rising expenditure on healthcare infrastructure across the globe
    • Increasing governmental push for advocating sustainability in healthcare
  • Market Restraints
    • Safety and efficacy concerns of reprocessed medical devices
  • Market Opportunities
    • Significant focus on outsourcing medical device reprocessing
    • Investments in R&D for developing superior sterilization methods
  • Market Challenges
    • Limitations of reprocessable devices, along with the absence of standardized reprocessing protocols

Porter's Five Forces: A Strategic Tool for Navigating the Medical Device Reprocessing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Medical Device Reprocessing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Medical Device Reprocessing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Medical Device Reprocessing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Medical Device Reprocessing Market

A detailed market share analysis in the Medical Device Reprocessing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Medical Device Reprocessing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Medical Device Reprocessing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Medical Device Reprocessing Market

A strategic analysis of the Medical Device Reprocessing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Medical Device Reprocessing Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Advanced Sterilization Products, Avante Health Solutions, Belimed AG, Cardinal Health, Inc., Ecolab USA Inc., Fujifilm Holdings Corporation, GE Healthcare Technologies Inc., Getinge AB, Innovative Health LLC, Johnson & Johnson Services, Inc., Karl Storz SE & Co. KG, Medifix Solutions Pty Ltd., Medline Industries, Inc., NEScientific, Inc., Olympus Corporation, Pioneer Medical Devices AG, ReNu Medical, Inc., Richard Wolf GmbH, Ruhof Corporation, Smith & Nephew PLC, Sotera Health Company, SteriPro Canada, Inc., Steris PLC, Stryker Corporation, SureTek Medical Inc., Teleflex Incorporated, UVC Solutions d.o.o., Vanguard AG, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Medical Device Reprocessing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Process, market is studied across Disinfection, Initial Cleaning, and Sterilization. The Disinfection is further studied across High-Level Disinfection and Intermediate-Level Disinfection. The Initial Cleaning is further studied across Automated Cleaning and Manual Cleaning. The Sterilization is further studied across Ethylene Oxide and Steam.
  • Based on Method of Deployment, market is studied across Off-Site Reprocessing and On-Site Reprocessing.
  • Based on Type, market is studied across Enzymatic and Non-Enzymatic Detergent.
  • Based on Reprocessing Medical Devices, market is studied across Cardiovascular, Gastroenterology, General Surgery, Laparoscopic, and Orthopedic/Arthroscopic.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Diagnostic Centers, and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing number of surgical procedures worldwide
      • 5.1.1.2. Rising expenditure on healthcare infrastructure across the globe
      • 5.1.1.3. Increasing governmental push for advocating sustainability in healthcare
    • 5.1.2. Restraints
      • 5.1.2.1. Safety and efficacy concerns of reprocessed medical devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Significant focus on outsourcing medical device reprocessing
      • 5.1.3.2. Investments in R&D for developing superior sterilization methods
    • 5.1.4. Challenges
      • 5.1.4.1. Limitations of reprocessable devices, along with the absence of standardized reprocessing protocols
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Process: Increased demand for steam sterilization ensuring safety and efficacy
    • 5.2.2. Reprocessing Medical Devices: Maximizing economic and sustainability benefits through medical device reprocessing in cardiovascular procedures
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Medical Device Reprocessing Market, by Process

  • 6.1. Introduction
  • 6.2. Disinfection
    • 6.2.1. High-Level Disinfection
    • 6.2.2. Intermediate-Level Disinfection
  • 6.3. Initial Cleaning
    • 6.3.1. Automated Cleaning
    • 6.3.2. Manual Cleaning
  • 6.4. Sterilization
    • 6.4.1. Ethylene Oxide
    • 6.4.2. Steam

7. Medical Device Reprocessing Market, by Method of Deployment

  • 7.1. Introduction
  • 7.2. Off-Site Reprocessing
  • 7.3. On-Site Reprocessing

8. Medical Device Reprocessing Market, by Type

  • 8.1. Introduction
  • 8.2. Enzymatic
  • 8.3. Non-Enzymatic Detergent

9. Medical Device Reprocessing Market, by Reprocessing Medical Devices

  • 9.1. Introduction
  • 9.2. Cardiovascular
  • 9.3. Gastroenterology
  • 9.4. General Surgery
  • 9.5. Laparoscopic
  • 9.6. Orthopedic/Arthroscopic

10. Medical Device Reprocessing Market, by End-User

  • 10.1. Introduction
  • 10.2. Ambulatory Surgical Centers
  • 10.3. Diagnostic Centers
  • 10.4. Hospitals & Clinics

11. Americas Medical Device Reprocessing Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Medical Device Reprocessing Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Medical Device Reprocessing Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. AA Medical announces strategic partnerships with Tekyard, Zantek Medical, and MED-SELLCOM to enhance healthcare asset management and reprocessing capabilities
    • 14.3.2. Getinge to acquire Healthmark Industries, expanding market reach and enhancing reprocessing solutions for healthcare facilities
    • 14.3.3. Olympus introduced an innovative ETD endoscope washer disinfector, enhancing safety, efficiency, and eco-friendliness in medical device reprocessing across the EMEA region
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Advanced Sterilization Products
  • 3. Avante Health Solutions
  • 4. Belimed AG
  • 5. Cardinal Health, Inc.
  • 6. Ecolab USA Inc.
  • 7. Fujifilm Holdings Corporation
  • 8. GE Healthcare Technologies Inc.
  • 9. Getinge AB
  • 10. Innovative Health LLC
  • 11. Johnson & Johnson Services, Inc.
  • 12. Karl Storz SE & Co. KG
  • 13. Medifix Solutions Pty Ltd.
  • 14. Medline Industries, Inc.
  • 15. NEScientific, Inc.
  • 16. Olympus Corporation
  • 17. Pioneer Medical Devices AG
  • 18. ReNu Medical, Inc.
  • 19. Richard Wolf GmbH
  • 20. Ruhof Corporation
  • 21. Smith & Nephew PLC
  • 22. Sotera Health Company
  • 23. SteriPro Canada, Inc.
  • 24. Steris PLC
  • 25. Stryker Corporation
  • 26. SureTek Medical Inc.
  • 27. Teleflex Incorporated
  • 28. UVC Solutions d.o.o.
  • 29. Vanguard AG
  • 30. Zimmer Biomet Holdings, Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦